碧迪医疗(Becton Dickinson) BDX
$211.88 −$1.67 (-0.78%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $211.88 0.00%
开盘$209.29
昨收$213.55
当日区间$208.95 – $214.88
成交量2.17M
市值$57.71B
市盈率（TTM）51.8
股息率1.98%
基本面
最新报告季度：Q3, ended Jun 2026
营收$4.98B+5.4% YoY
营业利润$752.00M-9.9% YoY
净利润$377.00M-34.3% YoY
摊薄每股收益$1.37-31.5% YoY
自由现金流$508.00M-51.9% YoY
经营现金流$651.00M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率46.9%
营业利润率14.5%
净利率4.2%
净资产收益率3.8%
资产收益率1.8%
投入资本回报率3.3%
流动比率0.87
负债/资产比率51.9%
现金及投资$709.00M
总负债$16.81B
净现金（净负债）-$16.10B
自由现金流/营收11.2%
营收构成
2026/Q3 季度
按业务线
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $4.98B | $4.71B | $5.25B | $21.84B | $8.30B |
| 营业总收入 | $4.98B | $4.71B | $5.25B | $21.84B | $8.30B |
| 营业成本 | $2.67B | $2.56B | $2.84B | $11.92B | $4.27B |
| 毛利润 | $2.32B | $2.15B | $2.41B | $9.93B | $4.03B |
| 营业费用 | $1.56B | $1.53B | $1.75B | $6.94B | $2.73B |
| 销售及管理费用 | $1.26B | $1.21B | $1.39B | $5.28B | $1.84B |
| 研发费用 | $258.00M | $249.00M | $306.00M | $1.27B | $559.00M |
| 其他营业费用 | $44.00M | $66.00M | $50.00M | $396.00M | $326.00M |
| 营业利润 | $752.00M | $626.00M | $662.00M | $2.99B | $1.30B |
| 非经营性利息净收入（支出） | -$128.00M | -$140.00M | -$149.00M | -$575.00M | -$148.00M |
| 非经营性利息收入 | $4.00M | $9.00M | $4.00M | $38.00M | $7.00M |
| 非经营性利息支出 | $132.00M | $149.00M | $153.00M | $613.00M | $155.00M |
| 其他收入（支出） | -$70.00M | -$447.00M | -$121.00M | -$531.00M | -$182.00M |
| 特殊收益（费用） | -$89.00M | -$533.00M | -$111.00M | -$408.00M | -$131.00M |
| -减：重组及并购费用 | $89.00M | $533.00M | – | $408.00M | $131.00M |
| 其他非经营性收入（支出） | $19.00M | $86.00M | -$10.00M | -$71.00M | $1.00M |
| 税前利润 | $554.00M | $39.00M | $393.00M | $1.88B | $975.00M |
| 税费 | $102.00M | $76.00M | $11.00M | $203.00M | $52.00M |
| 净利润 | $377.00M | -$311.00M | $382.00M | $1.68B | $493.00M |
| 持续经营利润 | $451.00M | -$37.00M | $382.00M | $1.68B | $923.00M |
| 终止经营净利润 | -$74.00M | -$274.00M | – | $0.00 | -$430.00M |
| 归属母公司净利润 | $377.00M | -$311.00M | $382.00M | $1.68B | $493.00M |
| 归属普通股股东净利润 | $377.00M | -$311.00M | $382.00M | $1.68B | $493.00M |
| 基本每股收益 | $1.37 | -$1.11 | $1.34 | $5.83 | $1.72 |
| 摊薄每股收益 | $1.37 | -$1.11 | $1.34 | $5.82 | $1.72 |
| 每股股息 | $1.05 | $1.05 | $1.05 | $4.16 | $1.04 |
| 证券出售收益 | – | – | – | -$52.00M | – |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $50.73B | $50.83B | $54.84B | $55.33B | $55.33B |
| 流动资产合计 | $8.14B | $8.01B | $9.19B | $9.26B | $9.26B |
| 现金及现金等价物与短期投资 | $709.00M | $816.00M | $751.00M | $649.00M | $649.00M |
| -现金及现金等价物 | $708.00M | $813.00M | $740.00M | $641.00M | $641.00M |
| -短期投资 | $1.00M | $3.00M | $11.00M | $8.00M | $8.00M |
| 应收款 | $2.36B | $2.21B | $2.51B | $2.99B | $2.99B |
| -应收账款 | $2.36B | $2.21B | $2.51B | $2.99B | $2.99B |
| 存货 | $3.32B | $3.36B | $4.09B | $3.89B | $3.89B |
| 受限现金 | $155.00M | $202.00M | $284.00M | $210.00M | $210.00M |
| 其他流动资产 | $1.60B | $1.43B | $1.56B | $1.51B | $1.51B |
| 非流动资产合计 | $42.59B | $42.82B | $45.65B | $46.07B | $46.07B |
| 固定资产净值 | $6.08B | $6.08B | $6.97B | $7.00B | $7.00B |
| -固定资产原值 | $13.60B | $13.55B | $15.24B | $15.11B | $15.11B |
| -累计折旧 | -$7.52B | -$7.47B | -$8.27B | -$8.12B | -$8.12B |
| 商誉及其他无形资产 | $33.96B | $34.30B | $35.64B | $36.02B | $36.02B |
| -商誉 | $25.94B | $25.96B | $26.62B | $26.61B | $26.61B |
| -其他无形资产 | $8.02B | $8.35B | $9.02B | $9.40B | $9.40B |
| 其他非流动资产 | $2.55B | $2.43B | $3.04B | $3.06B | $3.06B |
| 负债合计 | $26.32B | $26.70B | $29.56B | $29.94B | $29.94B |
| 流动负债合计 | $9.40B | $8.51B | $8.76B | $8.31B | $8.31B |
| 短期债务及融资租赁负债 | $3.30B | $2.57B | $2.62B | $1.56B | $1.56B |
| -一年内到期债务 | $3.30B | $2.57B | $2.62B | $1.56B | $1.56B |
| 非流动负债合计 | $16.91B | $18.19B | $20.80B | $21.62B | $21.62B |
| 长期债务及融资租赁负债 | $13.51B | $14.71B | $16.92B | $17.62B | $17.62B |
| -长期债务 | $13.51B | $14.71B | $16.92B | $17.62B | $17.62B |
| 员工福利 | $1.01B | $1.03B | $1.07B | $1.07B | $1.07B |
| 其他非流动负债 | $2.40B | $2.46B | $2.82B | $2.93B | $2.93B |
| 股东权益合计 | $24.42B | $24.13B | $25.28B | $25.39B | $25.39B |
| 股东权益 | $24.42B | $24.13B | $25.28B | $25.39B | $25.39B |
| 股本 | $371.00M | $371.00M | $371.00M | $371.00M | $371.00M |
| -普通股 | $371.00M | $371.00M | $371.00M | $371.00M | $371.00M |
| 资本公积 | $20.22B | $19.77B | $20.10B | $20.08B | $20.08B |
| 留存收益 | $17.51B | $17.39B | $16.70B | $16.62B | $16.62B |
| 减：库存股 | $12.06B | $11.66B | $10.06B | $9.81B | $9.81B |
| 不影响留存收益的损益 | -$1.65B | -$1.76B | -$1.86B | -$1.90B | -$1.90B |
| 其他权益权益 | $31.00M | $26.00M | $25.00M | $25.00M | $25.00M |
| 应付款 | – | – | – | $2.30B | $2.30B |
| -应付账款 | – | – | – | $1.97B | $1.97B |
| -应付税款合计 | – | – | – | $329.00M | $329.00M |
| 一年内应计费用 | – | – | – | $4.45B | $4.45B |
| 其他流动负债 | – | – | – | $1.00M | $1.00M |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $651.00M | $600.00M | $656.00M | $3.43B | $1.36B |
| 持续经营经营活动现金流净额 | $776.00M | $673.00M | $656.00M | $3.43B | $1.85B |
| 持续经营净利润 | $451.00M | -$108.00M | $382.00M | $1.68B | $923.00M |
| 持续经营损益 | $46.00M | -$124.00M | -$2.00M | $23.00M | $2.00M |
| 折旧、折耗与摊销 | $563.00M | $520.00M | $614.00M | $2.46B | $756.00M |
| 递延税款 | -$74.00M | -$73.00M | $29.00M | -$474.00M | -$222.00M |
| 其他非现金项目 | -$140.00M | -$48.00M | -$43.00M | $284.00M | $195.00M |
| 营运资金变动 | -$125.00M | -$2.00M | -$415.00M | -$800.00M | $120.00M |
| 终止经营经营活动现金流 | -$125.00M | – | – | $0.00 | -$498.00M |
| 投资活动现金流净额 | -$228.00M | -$192.00M | -$183.00M | -$818.00M | -$493.00M |
| 持续经营投资活动现金流净额 | -$241.00M | -$139.00M | -$183.00M | -$818.00M | -$589.00M |
| 资本支出 | -$143.00M | -$125.00M | -$108.00M | -$760.00M | -$377.00M |
| 业务购买及出售净额 | -$22.00M | $0.00 | $0.00 | $0.00 | -$13.00M |
| 投资购置及出售净额 | $4.00M | $23.00M | $0.00 | $422.00M | $14.00M |
| 其他投资变动净额 | -$80.00M | -$37.00M | -$75.00M | -$480.00M | -$213.00M |
| 筹资活动现金流 | -$650.00M | -$345.00M | -$301.00M | -$3.62B | -$810.00M |
| 持续经营筹资活动现金流净额 | -$576.00M | -$416.00M | -$301.00M | -$3.62B | -$810.00M |
| 债务发行及偿还净额 | -$283.00M | -$1.99B | $317.00M | -$1.33B | -$259.00M |
| 普通股发行净额 | $0.00 | -$2.00B | -$250.00M | -$1.00B | -$250.00M |
| 已付现金股利 | -$286.00M | -$290.00M | -$299.00M | -$1.20B | -$297.00M |
| 其他筹资费用净额 | -$7.00M | $3.86B | -$69.00M | -$87.00M | -$4.00M |
| 终止经营筹资活动现金流 | -$74.00M | – | – | – | – |
| 期末现金余额 | $863.00M | $1.02B | $1.03B | $851.00M | $851.00M |
| 现金净变动 | -$154.00M | $63.00M | $172.00M | -$1.01B | $58.00M |
| 期初现金余额 | $1.02B | $1.03B | $851.00M | $1.86B | $727.00M |
| 汇率变动影响 | $2.00M | $1.00M | $2.00M | $0.00 | $2.00M |
| 自由现金流 | $508.00M | $475.00M | $548.00M | $2.67B | $978.00M |
| -应收款变动 | – | – | – | $71.00M | – |
| -存货变动 | – | – | – | -$410.00M | – |
| -预付资产变动 | – | – | – | -$276.00M | – |
| -应付账款及应计费用变动 | – | – | – | -$185.00M | – |
暂无评论——快来第一个聊聊 BDX。
登录后参与讨论。